AcquisitionOther
AXIM BIOTECHNOLOGIES, INC. acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
AXIM BIOTECHNOLOGIES, INC. -> target · $1,090,000,
Valencia’s legal career began at a prestigious Wall Street law firm followed by a series of senior in-house counsel positions for several fast-growth companies including early stage Genentech.
Open source record (SEC) ↗